Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on: February 23,2024

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on:February 23,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024

Study finds combustion from gas stoves can raise indoor levels of chemical linked to blood cell cancers

by Rob Jordan,Stanford UniversityMean and median benzene emissions by fuel type (left panels; induction, coil, natural gas, and propane) and emissions from individual cooktop elements and ovens

Updated on: January 23,2024

Study finds combustion from gas stoves can raise indoor levels of chemical linked to blood cell cancers

by Rob Jordan,Stanford UniversityMean and median benzene emissions by fuel type (left panels; induction, coil, natural gas, and propane) and emissions from individual cooktop elements and ovens

Updated on:January 23,2024

Keeping aggressive cancer cells in check by blocking a protein responsible for repairs

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained

Updated on: January 07,2024

Keeping aggressive cancer cells in check by blocking a protein responsible for repairs

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained

Updated on:January 07,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on: March 01,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on:March 01,2024

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on: July 17,2024

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on:July 17,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on: April 07,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on:April 07,2024

Treatment shown to improve the odds against bone marrow cancer

by Newcastle UniversityCredit: CC0 Public DomainHope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and

Updated on: April 10,2024

Treatment shown to improve the odds against bone marrow cancer

by Newcastle UniversityCredit: CC0 Public DomainHope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and

Updated on:April 10,2024

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

Updated on: April 10,2024

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

Updated on:April 10,2024

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on: August 28,2024

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on:August 28,2024

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on: March 30,2024

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on:March 30,2024

Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

byFlinders UniversityGlioblastoma tumor cells express aberrant neuronal signatures and differentiate along a neurodevelopmental trajectory. (A) Healthy neuronal cells transform to a malignant ph

Updated on: January 15,2024

Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

byFlinders UniversityGlioblastoma tumor cells express aberrant neuronal signatures and differentiate along a neurodevelopmental trajectory. (A) Healthy neuronal cells transform to a malignant ph

Updated on:January 15,2024